세계의 초유 시장 : 공급원, 성질, 형태, 유통 채널, 용도, 지역별 예측 및 분석(-2032년)

According to Stratistics MRC, the Global Colostrum Market is accounted for $3.8 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 8.7% during the forecast period. The first type of milk that mammals generate right after birth is called colostrum. It is abundant in proteins, antibodies, and other necessary nutrients, giving babies growth factors and critical immunity. This yellowish fluid, rich in nutrients, aids in the development of the digestive system and guards against infections. Colostrum, sometimes referred to as "liquid gold," is essential for the development of the immune system early on and for general health.

According to the International Dairy Federation (IDF), global milk production reached 881 million tonnes in 2019, with over 6 billion people worldwide regularly consuming milk or other dairy products.

Market Dynamics:

Driver:

Growing awareness of health benefits

Increased scientific validation of its bioactive components, such as immunoglobulins and growth factors, has bolstered demand across nutraceuticals, sports nutrition, and infant formula sectors. Additionally, preventive healthcare trends post-pandemic have amplified its adoption. Marketing campaigns highlighting its role in combating infections and allergies further propel growth, particularly among health-conscious demographics. This awareness is driving product innovation and expanding applications in functional foods and dietary supplements.

Restraint:

Limited availability and seasonal supply

Harvesting colostrum requires precise timing post-calving, restricting production to specific periods. Moreover, ethical collection practices and stringent quality standards limit large-scale commercialization. Geographic concentration of dairy farms in regions like North America and Europe exacerbates supply chain bottlenecks, raising costs. These factors challenge manufacturers in meeting rising global demand, particularly for premium and organic variants. Seasonal fluctuations also lead to price volatility, impacting affordability and market penetration in price-sensitive regions.

Opportunity:

Growing demand for organic and natural products

Consumers increasingly prioritize clean-label, non-GMO, and hormone-free supplements, driving colostrum producers to adopt sustainable and ethical sourcing practices. Certifications such as USDA Organic and grass-fed claims enhance product appeal. Moreover, the expansion of e-commerce platforms facilitates access to niche markets. Innovations in cold-processing techniques to retain bioactive integrity further align with natural product trends, enabling differentiation in competitive markets like functional foods and infant nutrition.

Threat:

Ethical and animal welfare concerns

Ethical concerns regarding colostrum harvesting practices, particularly early separation of calves from cows, pose reputational risks. Animal welfare regulations and activism could lead to stricter compliance requirements, increasing production costs. Negative publicity around intensive dairy farming may deter ethically conscious consumers, pushing demand toward plant-based alternatives. Additionally, regulatory scrutiny in regions like Europe and North America could mandate transparency in sourcing, challenging suppliers to balance profitability with ethical practices.

Covid-19 Impact:

The Covid-19 pandemic initially disrupted colostrum supply chains due to labor shortages and logistics constraints. However, heightened consumer focus on immunity-boosting products accelerated demand, particularly in dietary supplements. Online sales surged as brick-and-mortar retail faced restrictions. Post-pandemic, sustained interest in preventive healthcare continues to drive growth, though inflationary pressures and raw material costs pose challenges. Manufacturers are investing in digital marketing and diversified sourcing to mitigate future disruptions

The cow segment is expected to be the largest during the forecast period

The cow segment is expected to account for the largest market share during the forecast period due to bovine colostrum's superior immunoglobulin concentration and widespread use in supplements, infant formula, and animal feed. Its compatibility with large-scale dairy farming and established research validating health benefits solidify its market leadership. Additionally, North America and Europe's robust dairy industries ensure consistent supply. Innovations in spray-dried and powdered forms further enhance accessibility, catering to diverse applications from sports nutrition to medical therapies.

The liquid segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the liquid segment is predicted to witness the highest growth rate driven by its convenience, bioavailability, and suitability for ready-to-drink formats. Rising demand for functional beverages and pediatric nutrition products, especially in emerging markets, fuels this trend. Moreover, advancements in preservation technologies extend shelf life without compromising nutrient integrity. The segment's versatility in combining with other health ingredients, such as probiotics, positions it for exponential growth in nutraceutical and clinical nutrition sectors.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to high health awareness, strong R&D investments, and a well-established nutraceutical industry. The U.S. dominates with a dense network of dairy farms and regulatory support for colostrum-based products. Rising demand for immune-boosting supplements and sports nutrition, coupled with premiumization trends, sustains market growth. Strategic collaborations between manufacturers and healthcare providers further reinforce regional dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by expanding middle-class populations, urbanization, and increasing disposable incomes. Countries like China and India witness surging demand for pediatric nutrition and functional foods. Government initiatives promoting maternal and child health, alongside rising awareness of colostrum's benefits, drive adoption. Additionally, e-commerce expansion and entry of global brands into untapped markets position the region for rapid growth, supported by a shift toward preventive healthcare post-pandemic.

Key players in the market

Some of the key players in Colostrum Market include NOW Foods, Cure Nutraceutical Pvt. Ltd., The Saskatoon Colostrum Company Ltd., Good Health Products Ltd, Sterling Technology, Deep Blue Health New Zealand Ltd., PanTheryx Inc., Biostrum Nutritech Pvt. Ltd., Colostrum BioTec GmbH, Biotaris B.V., Ingredia Nutritional, APS Biogroup Inc., La Belle Inc., Fonterra Co-operative Group Ltd., NIG Nutritionals Limited, Titan Biotech Ltd., Biodane Pharma A/S and Glanbia PLC.

Key Developments:

In August 2024, NOW(R), a family-owned brand that has been empowering the healthy living community for more than 55 years, makes significant and unique additions to its vast wellness portfolio with the launch of its Omega-3 Gummy Chews supplement and E-Sport Reaction gaming performance supplement, which are available online and at select natural retailers nationwide.

Sources Covered:

• Cow
• Buffalo
• Goat
• Sheep

Nature Covered:

• Conventional
• Organic

Forms Covered:

• Powder
• Liquid
• Capsules/Tablets

Distribution Channels Covered:

• Supermarkets/Hypermarkets
• Specialty Stores
• Online Retail
• Direct Sales

Applications Covered:

• Functional Foods and Beverages
• Dietary Supplements
• Sports Nutrition
• Infant Nutrition
• Animal Feed
• Cosmetics

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Colostrum Market, By Source

• 5.1 Introduction
• 5.2 Cow
• 5.3 Buffalo
• 5.4 Goat
• 5.5 Sheep

6 Global Colostrum Market, By Nature

• 6.1 Introduction
• 6.2 Conventional
• 6.3 Organic

7 Global Colostrum Market, By Form

• 7.1 Introduction
• 7.2 Powder
• 7.3 Liquid
• 7.4 Capsules/Tablets

8 Global Colostrum Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Supermarkets/Hypermarkets
• 8.3 Specialty Stores
• 8.4 Online Retail
• 8.5 Direct Sales

9 Global Colostrum Market, By Application

• 9.1 Introduction
• 9.2 Functional Foods and Beverages
• 9.3 Dietary Supplements
• 9.4 Sports Nutrition
• 9.5 Infant Nutrition
• 9.6 Animal Feed
• 9.7 Cosmetics

10 Global Colostrum Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 NOW Foods
• 12.2 Cure Nutraceutical Pvt. Ltd.
• 12.3 The Saskatoon Colostrum Company Ltd.
• 12.4 Good Health Products Ltd
• 12.5 Sterling Technology
• 12.6 Deep Blue Health New Zealand Ltd.
• 12.7 PanTheryx Inc.
• 12.8 Biostrum Nutritech Pvt. Ltd.
• 12.9 Colostrum BioTec GmbH
• 12.10 Biotaris B.V.
• 12.11 Ingredia Nutritional
• 12.12 APS Biogroup Inc.
• 12.13 La Belle Inc.
• 12.14 Fonterra Co-operative Group Ltd.
• 12.15 NIG Nutritionals Limited
• 12.16 Titan Biotech Ltd.
• 12.17 Biodane Pharma A/S
• 12.18 Glanbia PLC